gBETA Medtech aims to build community and foster innovation among the most promising of today’s early-stage startups.
U of M startup Aria CV, which uses a balloon-like device to treat pulmonary hypertension, recently won a Shark Tank Innovation Competition award.
U of M startup Calyxt recently signed a deal around its trans fat-free soybeans, developed through gene editing.
Minne Ties, a system for securing the jaw shut to promote proper healing following an injury, was licensed for commercial development through the U's Office for Technology Commercialization.
U of M startup enVerde, based on technology developed by Paul Dauenhauer that turns organic waste into synthetic gas, is seeking seed capital to establish a demonstration plant.
Ag-tech company Sentera's collaboration with the U of M was recently highlighted in an article on the company's recent Series A fundraising round.
The U of M-developed First Kiss apple was among the foods highlighted by a New York Times writer visiting the Minnesota State Fair.
A new technology developed at the U of M for “cryo-preserving” living biomaterials like fish embryos is now available for licensing.
U of M startup Calyxt was highlighted in a Wired article about the first high-quality, complete sequencing of the wheat genome.
The U of M will be a part of a new network designed to connected entrepreneurs with university startups in need of business leadership.
Sign up for the UMN Research newsletter >